The Asia Pacific Meningococcal Vaccine Market would witness market growth of 9.9% CAGR during the forecast period (2020-2026). Meningococcal vaccine manufacturers are focusing on the Asia Pacific region in order to capitalize for broadening treatment options for meningococcal disease in the region. As polysaccharide vaccines continue to show high traction from emerging countries owing to limited supply by limited vaccine manufacturers. That is why market forerunners team up with local distributors in order to expand their footprint. Furthermore, key market players, such as GlaxoSmithKline Plc., are capitalizing more to widening the range of age covered by meningococcal vaccines in the market.
The transmission of meningococcal bacteria, and unpredictable occurrences over time and across different age groups and geographies, have resulted in a substantial increase in the number of clinical programs for the effective development of meningococcal vaccines across the globe. Presently, around 30 ongoing clinical programs for the development of meningococcal vaccines at different stages. In the context of increasing government initiatives towards the development of meningococcal vaccines, the potential demand for these vaccines has increased.
Based on Brand, the market is segmented into Bexsero, Trumenba, Nimenrix, Menactra, Menveo and Other Brands. Based on Type, the market is segmented into Bivalent, Quadrivalent and Other Types. Based on Age Group, the market is segmented into Infants (0 to 2 years) and Children (2 years & above). Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: Meningococcal Vaccine Market in Asia Pacific is expected to register a CAGR of 9.9% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Pfizer, Inc., Sanofi S.A., Walvax Biotechnology Co., Ltd., Bio-Manguinhos (Oswaldo Cruz Foundation), Bio-Med Pvt. Ltd., Chongqing Zhifei Biological Products Co., Ltd., Hualan Biological Engineering, Inc., Incepta Pharmaceuticals Ltd. and Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
Scope of the Study
Market Segments Covered in the Report:
By Brand
- Bexsero
- Trumenba
- Nimenrix
- Menactra
- Menveo
- Other Brands
By Type
- Bivalent
- Quadrivalent
- Other Types
By Age Group
- Infants (0 to 2 years)
- Children (2 years & above)
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Sanofi S.A.
- Walvax Biotechnology Co., Ltd.
- Bio-Manguinhos (Oswaldo Cruz Foundation)
- Bio-Med Pvt. Ltd.
- Chongqing Zhifei Biological Products Co., Ltd.
- Hualan Biological Engineering, Inc.
- Incepta Pharmaceuticals Ltd.
- Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Meningococcal Vaccine Market, by Brand
1.4.2 Asia Pacific Meningococcal Vaccine Market, by Type
1.4.3 Asia Pacific Meningococcal Vaccine Market, by Age Group
1.4.4 Asia Pacific Meningococcal Vaccine Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Developments in Meningococcal Vaccine Market
Chapter 4. Asia Pacific Meningococcal Vaccine Market by Brand
4.1 Asia Pacific Bexsero Market by Country
4.2 Asia Pacific Trumenba Market by Country
4.3 Asia Pacific Nimenrix Market by Country
4.4 Asia Pacific Menactra Market by Country
4.5 Asia Pacific Menveo Market by Country
4.6 Asia Pacific Other Brands Market by Country
Chapter 5. Asia Pacific Meningococcal Vaccine Market by Type
5.1 Asia Pacific Bivalent Market by Country
5.2 Asia Pacific Quadrivalent Market by Country
5.3 Asia Pacific Other Types Market by Country
Chapter 6. Asia Pacific Meningococcal Vaccine Market by Age Group
6.1 Asia Pacific Children (2 years & above) and Adults Market by Country
6.2 Asia Pacific Infants(0 to 2 years) Market by Country
Chapter 7. Asia Pacific Meningococcal Vaccine Market by Country
7.1 China Meningococcal Vaccine Market
7.1.1 China Meningococcal Vaccine Market by Brand
7.1.2 China Meningococcal Vaccine Market by Type
7.1.3 China Meningococcal Vaccine Market by Age Group
7.2 India Meningococcal Vaccine Market
7.2.1 India Meningococcal Vaccine Market by Brand
7.2.2 India Meningococcal Vaccine Market by Type
7.2.3 India Meningococcal Vaccine Market by Age Group
7.3 Japan Meningococcal Vaccine Market
7.3.1 Japan Meningococcal Vaccine Market by Brand
7.3.2 Japan Meningococcal Vaccine Market by Type
7.3.3 Japan Meningococcal Vaccine Market by Age Group
7.4 South Korea Meningococcal Vaccine Market
7.4.1 South Korea Meningococcal Vaccine Market by Brand
7.4.2 South Korea Meningococcal Vaccine Market by Type
7.4.3 South Korea Meningococcal Vaccine Market by Age Group
7.5 Singapore Meningococcal Vaccine Market
7.5.1 Singapore Meningococcal Vaccine Market by Brand
7.5.2 Singapore Meningococcal Vaccine Market by Type
7.5.3 Singapore Meningococcal Vaccine Market by Age Group
7.6 Malaysia Meningococcal Vaccine Market
7.6.1 Malaysia Meningococcal Vaccine Market by Brand
7.6.2 Malaysia Meningococcal Vaccine Market by Type
7.6.3 Malaysia Meningococcal Vaccine Market by Age Group
7.7 Rest of Asia Pacific Meningococcal Vaccine Market
7.7.1 Rest of Asia Pacific Meningococcal Vaccine Market by Brand
7.7.2 Rest of Asia Pacific Meningococcal Vaccine Market by Type
7.7.3 Rest of Asia Pacific Meningococcal Vaccine Market by Age Group
Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.1 Financial Analysis
8.2.2 Segmental and Regional Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Approvals:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.4 Walvax Biotechnology Co., Ltd.
8.4.1 Company Overview
8.5 Bio-Manguinhos (Oswaldo Cruz Foundation)
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 Bio-Med Pvt. Ltd.
8.6.1 Company Overview
8.7 Chongqing Zhifei Biological Products Co., Ltd.
8.7.1 Company Overview
8.8 Hualan Biological Engineering, Inc.
8.8.1 Company Overview
8.9 Incepta Pharmaceuticals Ltd.
8.9.1 Company Overview
8.10. Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
TABLE 1 Asia Pacific Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 2 Asia Pacific Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 3 Asia Pacific Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 4 Asia Pacific Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 5 Asia Pacific Bexsero Market by Country, 2016 - 2019, USD Million
TABLE 6 Asia Pacific Bexsero Market by Country, 2020 - 2026, USD Million
TABLE 7 Asia Pacific Trumenba Market by Country, 2016 - 2019, USD Million
TABLE 8 Asia Pacific Trumenba Market by Country, 2020 - 2026, USD Million
TABLE 9 Asia Pacific Nimenrix Market by Country, 2016 - 2019, USD Million
TABLE 10 Asia Pacific Nimenrix Market by Country, 2020 - 2026, USD Million
TABLE 11 Asia Pacific Menactra Market by Country, 2016 - 2019, USD Million
TABLE 12 Asia Pacific Menactra Market by Country, 2020 - 2026, USD Million
TABLE 13 Asia Pacific Menveo Market by Country, 2016 - 2019, USD Million
TABLE 14 Asia Pacific Menveo Market by Country, 2020 - 2026, USD Million
TABLE 15 Asia Pacific Other Brands Market by Country, 2016 - 2019, USD Million
TABLE 16 Asia Pacific Other Brands Market by Country, 2020 - 2026, USD Million
TABLE 17 Asia Pacific Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 18 Asia Pacific Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 19 Asia Pacific Bivalent Market by Country, 2016 - 2019, USD Million
TABLE 20 Asia Pacific Bivalent Market by Country, 2020 - 2026, USD Million
TABLE 21 Asia Pacific Quadrivalent Market by Country, 2016 - 2019, USD Million
TABLE 22 Asia Pacific Quadrivalent Market by Country, 2020 - 2026, USD Million
TABLE 23 Asia Pacific Other Types Market by Country, 2016 - 2019, USD Million
TABLE 24 Asia Pacific Other Types Market by Country, 2020 - 2026, USD Million
TABLE 25 Asia Pacific Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 26 Asia Pacific Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 27 Asia Pacific Children (2 years & above) and Adults Market by Country, 2016 - 2019, USD Million
TABLE 28 Asia Pacific Children (2 years & above) and Adults Market by Country, 2020 - 2026, USD Million
TABLE 29 Asia Pacific Infants(0 to 2 years) Market by Country, 2016 - 2019, USD Million
TABLE 30 Asia Pacific Infants(0 to 2 years) Market by Country, 2020 - 2026, USD Million
TABLE 31 Asia Pacific Meningococcal Vaccine Market by Country, 2016 - 2019, USD Million
TABLE 32 Asia Pacific Meningococcal Vaccine Market by Country, 2020 - 2026, USD Million
TABLE 33 China Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 34 China Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 35 China Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 36 China Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 37 China Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 38 China Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 39 China Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 40 China Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 41 India Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 42 India Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 43 India Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 44 India Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 45 India Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 46 India Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 47 India Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 48 India Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 49 Japan Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 50 Japan Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 51 Japan Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 52 Japan Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 53 Japan Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 54 Japan Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 55 Japan Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 56 Japan Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 57 South Korea Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 58 South Korea Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 59 South Korea Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 60 South Korea Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 61 South Korea Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 62 South Korea Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 63 South Korea Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 64 South Korea Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 65 Singapore Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 66 Singapore Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 67 Singapore Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 68 Singapore Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 69 Singapore Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 70 Singapore Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 71 Singapore Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 72 Singapore Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 73 Malaysia Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 74 Malaysia Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 75 Malaysia Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 76 Malaysia Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 77 Malaysia Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 78 Malaysia Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 79 Malaysia Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 80 Malaysia Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 81 Rest of Asia Pacific Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 82 Rest of Asia Pacific Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 83 Rest of Asia Pacific Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 84 Rest of Asia Pacific Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 85 Rest of Asia Pacific Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 86 Rest of Asia Pacific Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 87 Rest of Asia Pacific Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 88 Rest of Asia Pacific Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 89 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 90 Key Information – Pfizer, Inc.
TABLE 91 Key Information – Sanofi S.A.
TABLE 92 Key Information – Walvax Biotechnology Co., Ltd.
TABLE 93 Key Information – Bio-Manguinhos
TABLE 94 key information – Bio-Med Pvt. Ltd.
TABLE 95 key Information – Chongqing Zhifei Biological Products Co., Ltd.
TABLE 96 Key Information – Hualan Biological Engineering, Inc.
TABLE 97 key information – Incepta Pharmaceuticals Ltd.
TABLE 98 Key Information – Serum Institute of India Pvt. Ltd.
List of Figures
FIG 1 Methodology for the research